It was certainly disappointing reading about these "minor impurities" in the first batch but demanding they give us a chemical analysis of the impurity in an asx announcement is over the top. I'm guessing if they don't pass TGA muster then they'll have to be remanufactured and it will be the manufacturer who has the responsibility but of course that still means more schedule slippage.
Ann: MPL tablets arrive in Melbourne for MND Clinical Trial, page-34
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.015(6.98%) |
Mkt cap ! $111.9M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 23.0¢ | 21.5¢ | $475.3K | 2.128M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 93524 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 71004 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |